Corporate Support
Sitemap

Features

Customer Services

Events

Terms of Use

Singapore
Malaysia

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,973.5
49.0 (1.67%)

 

  • STI Straits Times Index
    2,973.5
    49.0 (1.67%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,581.5
    24.0 (1.54%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    30,074.2
    355.9 (1.20%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    3,585.0
    21.0 (0.59%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    29,671.7
    -
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    6,289.6
    38.6 (0.62%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,898.3M
  • Value: 1,929.3M
  • Rise: 245
  • Fall: 121
  • Unch: 410

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol

  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Thomson Medical0.119+0.010
Shen Yao0.004-
Oceanus^0.075+0.004
Secura0.103+0.017
Jiutian Chemical0.095-0.001
Sembcorp Marine0.155+0.003
ThaiBev0.735+0.015
YZJ Shipbldg SGD1.060+0.020
Singtel2.380-
SIA5.030+0.340

World Indices

World Indices
Name Last Change
Nasdaq 13,598.0 +132.8
HSI 30,074.2 +355.9
HSCEI 11,717.4 +207.7
Jakarta 6,289.6 +38.6
Nikkei 225 29,671.7
SSE Comp 3,585.0 +21.0
Shanghai A 3,758.0 +22.0
Shanghai B 245.9
KOSPI 3,099.7 +104.7

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help

  • Factsheet

  • Print

Diagnos Laboratorium Utama Tbk. Diagnos Laboratorium Utama Tbk.
Quotes 10 Minutes Delayed. Updated at 25 Feb 2021 15:12
Last (IDR): 705.000 Change: -50.000 High: 755.000 Remarks: -
Change (%): -6.62 Low: 705.000
Open 755.000 Yesterday's Close 755.000
Buy Price - Sell Price 705.000
Buy Volume ('000) - Sell Volume ('000) 775.2
Cumulative Volume ('000) 25,731.9 Cumulative Value 18,242,000,000
 
Click to show Stock Prices chart

Key Statistics

EPS (IDR) a 7.41967 Trailing EPS (IDR) e 7.41967 NAV (IDR) b 37.1675
PE a 95.018 Trailing PE f 95.018 Price / NAV b 18.9682
Dividend (IDR) d - Cash In Hand (IDR) g 1.1147 Issued & Paid-up Shares c 1,250,000,000
Dividend Yield (%) d - Price / Cash In Hand g 632.457 Treasury Shares h -
Beta - 75 Daysi -2.803 R-Squared - 75 Days(%)i 4.87 Market Cap (M) 881,250.000
Beta - 500 Daysi -2.676 R-Squared - 500 Days (%)i 5.06 Enterprise Value (M) 883,345.844
Piotroski F Score 5 Exchange Code DGNS Par Value ( IDR ) 25.00000
52 Weeks Volatility (%) n.a. 6-Month VWAP n.a. Free Float (%) -
Sector & Industry Health Services - Medical/Nursing Services
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 18 Jan 2021.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 18 Jan 2021.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference Diagnos Laboratorium Utama Tbk. IDX 881,250.000 95.018 95.018 18.9682 -
Industry Medical/Nursing Services IDX 5,492,625.000 - 607.399 3.2957 -
Local Peer Metro Healthcare Indonesia Tbk. IDX 10,108,000.000 - 1,147.184 3.0754 -
Global Peer JD HEALTH HKEx 464,281.146 - - -72.6711 -
Global Peer FRESENIUS MEDICAL CARE AG & CO KGAA SPON ADR-EACH REP 0.5 NPV NYSE 20,712.474 15.426 13.893 1.5368 1.434
Global Peer PA GOODDOCTOR HKEx 135,265.491 - - 7.2055 -
Global Peer GUARDANT HEALTH INC NASDAQ 16,258.719 - - 14.8862 -
Global Peer OAK STREET HEALTH INC NYSE 13,723.206 - - 29.8133 -
Global Peer SONIC HEALTHCARE ASX 15,797.059 29.933 57.790 - 2.557
Global Peer DAVITA INC NYSE 11,256.166 14.370 14.370 8.1356 -
Global Peer NATERA INC NASDAQ 9,632.286 - - 17.9706 -
Global Peer AMEDISYS INC NASDAQ 9,240.835 72.858 55.624 12.2200 -
Global Peer INVITAE CORP NYSE 7,813.251 - - 3.9669 -
Other Global Peers CHEMED CORP (NYSE), 1LIFE HEALTHCARE INC (NASDAQ), LHC GROUP INC (NASDAQ), NEOGENOMICS INC (NASDAQ), JXR (HKEx), ACADIA HEALTHCARE (NASDAQ), SMILEDIRECTCLUB INC (NASDAQ), ENSIGN GROUP INC (NASDAQ), NH HEALTH-B (HKEx), OPTION CARE HEALTH INC (NASDAQ), BURNING ROCK BIOTECH LTD SPON ADS EACH REP 1 ORD SHS CL A (NASDAQ), FULGENT GENETICS INC (NASDAQ), GENETRON HOLDINGS LIMITED SPON ADS EACH REP 5 ORD SHS (NASDAQ), CASTLE BIOSCIENCES INC (NASDAQ), MEDNAX INC (NYSE), HEALIUS LTD (ASX), ADDUS HOMECARE CORP (NASDAQ), US PHYSICAL THERAPY (NYSE), PENNANT GROUP INC (NASDAQ), SVH (SET), TIVITY HEALTH INC (NASDAQ), ONTRAK INC (NASDAQ), RAM (SET), UM HEALTHCARE (HKEx), KPJ (Bursa), RADNET INC (NASDAQ), C-MER EYE (HKEx), HANGER INC (NYSE), APRIA INC (NASDAQ), OCEANIA HEALTHCARE LTD (ASX), BIODESIX INC (NASDAQ), GLOBAL CORD BLOOD CORPORATION (NYSE), VIRTUS HEALTH LIMITED (ASX), EUROEYES (HKEx), CARDIFF ONCOLOGY INC (NASDAQ), PROGENITY INC (NASDAQ), GLOBAL X FDS ARTIFICIAL INTELLIGENCE AND TECH ETF (NASDAQ), CRH MEDICAL CORP (NYSE American), SANARA MEDTECH INC (NASDAQ), AKUMIN INC (NASDAQ), EXAGEN INC (NASDAQ), APTINYX INC (NASDAQ), OPTINOSE INC (NASDAQ), ONCOSEC MEDICAL INCORPORATED (NASDAQ), AESTHETIC MEDICAL INT HLDGS GRP LTD SPON ADS EACH REP 3 ORD SHS (NASDAQ), CLOVER CORP (ASX), BARD1 LIFE SCIENCES LTD (ASX), SILK LASER AUSTRALIA LTD (ASX), NOVO INTEGRATED SCIENCES INC (NASDAQ), RAILY AESMED (HKEx), HEALTHIA LTD (ASX), CONCORD MEDICAL SERVICES HLDGS LTD ADS EACH 1 REPR 3 ORD SHS (USD0.0001) (NYSE), PRO-DEX INC (NASDAQ), OPTIMAX (Bursa), UMP (HKEx), BIOCEPT INC (NASDAQ), GUARDION HEALTH SCIENCES INC (NASDAQ), ORTHOCELL LIMITED (ASX), GBS INC (NASDAQ), Clearbridge (SGX), CAPITAL SENIOR LIVING CORP (NYSE), Cordlife (SGX), Asian Healthcare (SGX), MHCARE (Bursa), KDH (SET), HC Surgical (SGX), HUMAN HEALTH (HKEx), D (SET), Sing Paincare (SGX), IMAC HOLDINGS INC (NASDAQ), TOTAL BRAIN LTD (ASX), Alliance HC (SGX), RMH HOLDINGS (HKEx), CHINA HEALTH (HKEx), Medinex (SGX), AsiaMedic (SGX), LIFESPOT HEALTH LTD (ASX), AMERICAN SHARED HOSPITAL SERVICES (NYSE American), SMILE (Bursa), RHT HealthTrust (SGX), REPUBLIC HC (HKEx), MOHO RESOURCES NL (ASX), SMILES INCLUSIVE LTD (ASX), TOPVISN (Bursa)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --20.000
-2.76 %
10 Days -+10.000
+1.44 %
20 Days -+105.000
+17.50 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 270.000 - 935.000 Change From 1 Year Low +435.000 % Change From 1 Year Low (%) +161.11
Change From 1 Year High -230.000 % Change From 1 Year High (%) -24.60
2 Years Range 270.000 - 935.000 Change From 2 Years Low +435.000 % Change From 2 Years Low (%) +161.11
Change From 2 Years High -230.000 % Change From 2 Years High (%) -24.60
5 Years Range 270.000 - 935.000 Change From 5 Years Low +435.000 % Change From 5 Years Low (%) +161.11
Change From 5 Years High -230.000 % Change From 5 Years High (%) -24.60
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

PT Diagnos Laboratorium Utama Tbk engages in the provision of medical laboratory testing services. It offers anatomic pathology, chemistry immunology, clinical microscopy, hematology microbiology, 2D echo, CT Scan, electrocardiogram, impedance cardiography, mammography, ultrasound, vascular studies, X-ray, and polymerase chain reaction (“PCR”) tests. The company was founded on August 29, 2009 and is headquartered in Jakarta, Indonesia.

Historical Price Data

Date Open High Low Close Volume VWAP
25 Feb 2021 755.000 755.000 705.000 705.000 25,731,900 708.9255
24 Feb 2021 810.000 935.000 755.000 755.000 75,979,000 847.8115
23 Feb 2021 690.000 815.000 680.000 810.000 57,583,200 765.8480
22 Feb 2021 675.000 700.000 660.000 685.000 16,546,300 686.3739
19 Feb 2021 680.000 700.000 645.000 670.000 3,419,900 669.5750
18 Feb 2021 725.000 740.000 675.000 675.000 24,008,400 700.2816
17 Feb 2021 700.000 760.000 650.000 725.000 35,846,700 712.1070
16 Feb 2021 645.000 710.000 645.000 695.000 25,110,200 675.9417
15 Feb 2021 655.000 675.000 610.000 645.000 11,904,900 654.0806
11 Feb 2021 695.000 710.000 650.000 655.000 12,361,300 684.1312
10 Feb 2021 755.000 790.000 695.000 695.000 49,673,100 729.3390
09 Feb 2021 620.000 750.000 600.000 745.000 56,254,700 689.6581
08 Feb 2021 565.000 635.000 565.000 615.000 30,192,700 598.2242
05 Feb 2021 645.000 650.000 605.000 605.000 448,800 605.5091
04 Feb 2021 680.000 695.000 650.000 650.000 538,800 651.5200
03 Feb 2021 750.000 750.000 695.000 695.000 1,704,800 696.9961
02 Feb 2021 760.000 790.000 740.000 745.000 13,609,600 756.3342
01 Feb 2021 730.000 830.000 730.000 760.000 28,922,800 782.5623
29 Jan 2021 760.000 870.000 740.000 770.000 82,355,100 816.2688
28 Jan 2021 605.000 750.000 600.000 750.000 56,770,700 706.4943
27 Jan 2021 515.000 605.000 515.000 600.000 34,438,000 562.5099
26 Jan 2021 595.000 600.000 550.000 550.000 6,024,400 555.3965
Summary
Current 2 Weeks
(11 Feb 2021 to 25 Feb 2021)		 695.000 935.000 610.000 705.000 288,491,800 -
Previous 2 Weeks
(28 Jan 2021 to 10 Feb 2021)		 605.000 935.000 600.000 695.000 320,471,100 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.